Professional Documents
Culture Documents
INTRODUCTION
2.AIMS
3.RESPONSIBILITIES
4.NEED OF PHARMACOVIGILANCE
5.GOVERNING BODIES
6.METHODS OF PHARMACOVIGILANCE
7. PHARMACOVIGILANCE INSPECTION
8.ADVERSE DRUG REACTION
9.APPLICATION OF PHARMACOVIGILANCE
10.TERMINOLOGY
11.POST MARKETING SURVEILLANCE
12. PHARMACOVIGILANCE PROGRAMME IN INDIA
13.WHO PROGRAMME FOR INTERNATIONAL DRUG
MONITORING
14.PHARMACOVIGILANCE OF MEDICAL DEVICES
15.PHARMACOVIGILANCE OF HERBAL MEDICINES
Pharmacovigilance(PV) also called as drug
safety
Pharmakon-------in greek----drug
Vigilare -----------in latin------to keep watch
1.Routine inspections
- To make sure that pharmaceutical companies
have the ability in performing Pharmacovigilance
activities
2.targeted inspections
a) inspections irrelevant to drug safety
-companies that have not yet been inspected
-companies that launch their first product
-companies which are newly merged
6.teratogenicity:
-Fetal abnormalities produced due to drug
intake by the pregnant woman
Ex-androgens cause virilization of fetus
7.non immunological activation of effector
pathways:
-Some drugs cause release of mediators
from mast cells resulting in urticaria.
Ex-radio contrast media
8.exacerbation of disease :
-Barbiturates precipitate symptoms of
porphyria
9.metabolic alterations :
Ex- isotretinoin interferes with VLDL
metabolism and causes xanthoma
11.effect on spermatogenesis:
-Cytotoxic drugs causes oligospermia.
Type B
1.intolerance:
-Appearance of toxic effects in a recipient to
therapeutic doses of drug
Ex- trifluperazine single dose causing
muscle dystonia in children
2.idiosyncrasy:
-Uncertain reaction to a drug in a genetically
defect patient
Ex-chloramphenicol causes bone marrow
depression
IMMUNOLOGICAL
1.Type 1 (immediate or anaphylactic):
Earlier exposure
AB formed
Re exposure to the
AG:AB reaction
same Drug (AG)
mast cells
Mediators
urticaria
Ex:-penicillin, lignocaine
2.Type 2 (cytotoxic):
Drug + particular tissue AB
(AG)
AG:AB reaction
complement
cytolysis
AG : AB complex
Complement
Inflammatory reaction
Release of lymphokines
Attracts granulocytes
Inflammatory response
Ex:-contact dermatitis
MISCELLANEOUS
1.jarisch-herxheimer reaction:
-This is seen when an infective disease is
treated with antimicrobials , due to release of
active substances from dead micro organisms
and injured tissue resulting in focal
exacerbation of the lesions.
2.infectious mononucleosis:
-Ampicillin induced morbilliform rash in
patients suffering from infectious
mononucleosis.
Steps of ADR monitoring:
1.identifying adverse drug reactions
2.assessing causality
3.documentation of ADR
18.PHARMACOGENOMICS-application of
genomic technologies to new drug discovery.
19.PHARMACOENVIRONMENTOLOGY-form of
pharmacovigilance which deals specifically
with those pharmacological agents that have
impact on the environment via elimination
through living organisms subsequent to
pharmacotherapy.
Post marketing surveillance(PMS)
objectives-
1. to monitor ADRs
Technical support by –
1.signal review panel
2.core training panel
3.quality review panel
STEERING COMMITTEE
Chairman-drugs controller general (India), New Delhi
Members-
1.scientific director , Indian pharmacopoeia commission ,
Ghaziabad
Functions –
1. identification and analysis of new ADR signals from
national centres & sent to the WHO ICSR database
8. annual meetings
9. research on Pharmacovigilance
REPORTING TRENDS:
1. preferred report format is the ICH E2B